Dr Dahna Maree Fong

Selected publications and creative works (Research Outputs)

As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your Research Outputs profile up to date.
  • Griffin, J. M., Fackelmeier, B., Clemett, C. A., Fong, D. M., Mouravlev, A., Young, D., & O'Carroll SJ (2020). Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury. Experimental neurology, 32710.1016/j.expneurol.2020.113232
    Other University of Auckland co-authors: Deborah Young, Simon OCarroll, Connor Clemett, Alexandre Mouravlev
  • Griffin, J. M., Fackelmeier, B., Fong, D. M., Mouravlev, A., Young, D., & O'Carroll SJ (2019). Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury. Gene therapy, 26 (5), 198-210. 10.1038/s41434-019-0075-6
    Other University of Auckland co-authors: Deborah Young, Simon OCarroll
  • Fong, D. M., Wu, A., & Young, D. (2018). Targeting transgene and RNA interference-based gene silencing sequences to astrocytes using viral vector-mediated approaches. In M. Li, B. Snider (Eds.) Gene therapy in neurological disorders (pp. 41-61). London, UK: Academic Press. 10.1016/B978-0-12-809813-4.00002-8
    URL: http://hdl.handle.net/2292/47800
    Other University of Auckland co-authors: Deborah Young
  • Mudannayake, J. M., Mouravlev, A., Fong, D. M., & Young, D. (2016). Transcriptional activity of novel ALDH1L1 promoters in the rat brain following AAV vector-mediated gene transfer. Molecular Therapy - Methods & Clinical Development, 3 (16075), 1-10. 10.1038/mtm.2016.75
    Other University of Auckland co-authors: Deborah Young, Alexandre Mouravlev
  • Naidoo, J., Fong, D., Mouravlev, A., & Young, D. (18/10/2015). Neuroprotective efficacy of a calpain-dependent gene regulation system expressing X-linked inhibitor of apoptosis protein in a model of Parkinson’s disease. Poster presented at Society for Neuroscience: Neuroscience 2015, Chicago, USA. Society for Neuroscience:.
    Other University of Auckland co-authors: Deborah Young, Alexandre Mouravlev
  • Mudannayake, J., Fong, D., Mouravlev, A., & Young, D. (17/10/2015). Adeno-associated viral vector serotype 5 (AAV5) mediates efficient neuronal and astrocytic therapeutic transgene expression in the substantia nigra pars compacta (SNpc). Poster presented at Society for Neuroscience: Neuroscience 2015, Chicago, Illinois.
    Other University of Auckland co-authors: Alexandre Mouravlev
  • Wu, A., Fong, D. M., & Young, D. (2015). Gene therapy for Huntington’s disease. (pp. 121-151). 10.1007/978-1-4939-2306-9_5
    Other University of Auckland co-authors: Angela Wu
  • Wu, A., Fong, D., & Young, D. (2015). Gene therapy for Huntington's disease. In X. Bo, J. Verhaagen (Eds.) Gene Delivery and Gene Therapy for Neurological Disorders (pp. 121-155). Springer. 10.1007/978-1-4939-2306-9
    Other University of Auckland co-authors: Deborah Young

Contact details

Primary office location

M&HS BUILDING 502 - Bldg 502
Level 5, Room 501
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand